Biocon Biologics’ $800 Million High Yield Bond Issuance

Marco Zingaro Asia & Pacific Legal Chronicle
Tagged:

Latham & Watkins has advised the lead managers on the offering. Linklaters advised Biocon Biologics.Biocon Biologics Plc, a wholly owned subsidiary of Biocon Biologics Limited (BBL), completed…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Marco Zingaro

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here